Overall Survival with Daratumumab, Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma (Alcyone): a Randomised, Open-Label, Phase 3 Trial

AuthID
P-00R-KAR
30
Author(s)
Mateos, MV
·
Cavo, M
·
Blade, J
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
[+2]·
[+1]·
[+2]·
[+2]·
[+1]·
[+2]·
Kudva, A
·
Wroblewski, S
·
Qi, M
·
Document Type
Article
Year published
2020
Published
in LANCET, ISSN: 0140-6736
Volume: 395, Issue: 10218, Pages: 132-141 (10)
Indexing
Publication Identifiers
Wos: WOS:000506652400030
Source Identifiers
ISSN: 0140-6736
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Mateos, MV;   2 Cavo, M;   3 Blade, J;
4 Dimopoulos, MA;   5 Suzuki, K;   6 Jakubowiak, A;
7 Knop, S;   8 Doyen, C;   9 Lucio, P;
10 Nagy, Z;   11 Pour, L;   12 Cook, M;
13 Grosicki, S;   14 Crepaldi, A;   15 Liberati, AM;
16 Campbell, P;   17 Shelekhova, T;   18 Yoon, SS;
19 Iosava, G;   20 Fujisaki, T;   21 Garg, M;
22 Krevvata, M;   23 Chen, Y;   24 Wang, JP;
25 Kudva, A;   26 Ukropec, J;   27 Wroblewski, S;
28 Qi, M;   29 Kobos, R;   30 San Miguel, J;